000 01325 a2200337 4500
005 20250515193506.0
264 0 _c20100119
008 201001s 0 0 eng d
022 _a0214-0934
024 7 _a10.1358/dnp.2009.22.7.1400219
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFichna, Jakub
245 0 0 _aSelective natural kappa opioid and cannabinoid receptor agonists with a potential role in the treatment of gastrointestinal dysfunction.
_h[electronic resource]
260 _bDrug news & perspectives
_cSep 2009
300 _a383-92 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAnimals
650 0 4 _aCannabinoid Receptor Agonists
650 0 4 _aDiterpenes, Clerodane
_xpharmacology
650 0 4 _aGastrointestinal Diseases
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aPsychotropic Drugs
_xpharmacology
650 0 4 _aReceptors, Opioid, kappa
_xagonists
650 0 4 _aSalvia
_xchemistry
700 1 _aSchicho, Rudolf
700 1 _aJanecka, Anna
700 1 _aZjawiony, Jordan K
700 1 _aStorr, Martin
773 0 _tDrug news & perspectives
_gvol. 22
_gno. 7
_gp. 383-92
856 4 0 _uhttps://doi.org/10.1358/dnp.2009.22.7.1400219
_zAvailable from publisher's website
999 _c19278539
_d19278539